PL370634A1 - Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides - Google Patents

Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Info

Publication number
PL370634A1
PL370634A1 PL02370634A PL37063402A PL370634A1 PL 370634 A1 PL370634 A1 PL 370634A1 PL 02370634 A PL02370634 A PL 02370634A PL 37063402 A PL37063402 A PL 37063402A PL 370634 A1 PL370634 A1 PL 370634A1
Authority
PL
Poland
Prior art keywords
polypeptides
factor
pharmaceutical composition
factor vii
vii polypeptides
Prior art date
Application number
PL02370634A
Other languages
English (en)
Polish (pl)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Health Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Health Care Ag filed Critical Novo Nordisk Health Care Ag
Publication of PL370634A1 publication Critical patent/PL370634A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4846Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02370634A 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides PL370634A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09

Publications (1)

Publication Number Publication Date
PL370634A1 true PL370634A1 (en) 2005-05-30

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370634A PL370634A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides

Country Status (16)

Country Link
EP (1) EP1446149A1 (cs)
JP (1) JP2005511599A (cs)
KR (1) KR20050043734A (cs)
CN (1) CN1596125A (cs)
AU (1) AU2002340779B2 (cs)
BR (1) BR0213953A (cs)
CA (1) CA2464615A1 (cs)
CZ (1) CZ2004543A3 (cs)
HU (1) HUP0401985A3 (cs)
IL (1) IL161544A0 (cs)
MX (1) MXPA04004304A (cs)
NO (1) NO20042380L (cs)
PL (1) PL370634A1 (cs)
RU (1) RU2004117534A (cs)
WO (1) WO2003039584A1 (cs)
ZA (1) ZA200403271B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0302052A3 (en) 1999-07-14 2005-12-28 Novo Nordisk Healthcare Ag Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
EP1713496A1 (en) * 2004-02-05 2006-10-25 Novo Nordisk Health Care AG Use of factor viia for treating trauma
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
DK2004214T3 (da) 2006-03-16 2013-02-18 Stellaris Pharmaceuticals Aps Lokalbehandling med faktor VII
EP3065768B1 (en) * 2013-11-04 2020-09-23 The Regents of the University of California Composition for use in treatment or prevention of conditions associated with bleeding or hypocoagulationcompostion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083905A (en) * 1994-04-22 2000-07-04 Stichting Sanquin Bloedvoorziening Method and means for detecting and treating disorders in the blood coagulation cascade
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
JP2002514433A (ja) * 1998-05-14 2002-05-21 バッテル メモリアル インスティテュート トランスジェニック植物由来ヒト凝血因子

Also Published As

Publication number Publication date
KR20050043734A (ko) 2005-05-11
WO2003039584A1 (en) 2003-05-15
HUP0401985A3 (en) 2009-03-30
HUP0401985A2 (hu) 2004-12-28
BR0213953A (pt) 2004-08-31
JP2005511599A (ja) 2005-04-28
CN1596125A (zh) 2005-03-16
AU2002340779B2 (en) 2007-08-02
RU2004117534A (ru) 2005-05-10
NO20042380L (no) 2004-06-08
MXPA04004304A (es) 2004-08-11
CZ2004543A3 (cs) 2004-08-18
CA2464615A1 (en) 2003-05-15
IL161544A0 (en) 2004-09-27
EP1446149A1 (en) 2004-08-18
ZA200403271B (en) 2004-11-08

Similar Documents

Publication Publication Date Title
HUP0500989A2 (en) Animicrobial polypeptides and their uses
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL159015A0 (en) Polypeptides, their preparation and use
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
GB0108470D0 (en) Pharmaceutical compositions and their use
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
IL159872A0 (en) Gmg-2 polypeptides and their use
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
HUP0400976A3 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
IL158397A0 (en) Polypeptides, their preparation and their use
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
EP1496834A4 (en) HIGH AFFINITY INTEGRIN POLYPEPTIDES AND THEIR APPLICATIONS
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
IL161544A0 (en) Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
IL131266A0 (en) Peptides and pharmaceutical compositions comprising same
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
IL161523A0 (en) Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
GB0013503D0 (en) Pharmaceutical compositions and their uses

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)